Technician Mike Lattari prepares a flow cell slide for loading onto a genetic sequencing machine at a Regeneron Pharmaceuticals Inc. laboratory in Tarrytown, NY, in this March 24, 2015, file photo. Two groups of researchers have identified potential increased cancer risk in some cells as a result of gene editing with CRISPR-Cas9 technology.
http://www.cbc.ca/news/health/gene-editing-tool-cancer-risk-crispr-1.4700971?cmp=rss
No comments:
Post a Comment